New innovations in syphilis analyzers are becoming increasingly mainstream in the syphilis immunoassay diagnostics market. As such, companies are launching new technologies in analyzers. For instance, in April 2019, Gold Standard Diagnostics - a provider of comprehensive diagnostic solutions, revealed the launch of its proprietary technology with a U.S. patent, which performs serological testing for syphilis.
Advancements in analyzer technologies are creating incremental opportunities for healthcare companies in the syphilis immunoassay diagnostics market space. There is increasing demand for advanced analyzers in hospitals and blood banks due to increase in the spending capacity of patients with STDs. Companies in the syphilis immunoassay diagnostics market are innovating in new technologies with the help of dedicated machines to automate rapid plasma regain (RPR) assays. They are improving testing capabilities for laboratories with the help of new software developments to enhance outcomes in patients.
Novel approaches of technological automation and machine learning are being adopted to develop first-of-its-kind diagnostics systems. The combination of approaches is helping clinical laboratories offer high-quality solutions for syphilis testing.
To know the scope of our report Get a Sample on Syphilis Immunoassay Diagnostics Market
The growing trend of on-the-spot testing solutions has led to improvements in the syphilis immunoassay diagnostics landscape. For instance, clinical diagnostics company MBio, announced the launch of the LightDeck® platform, an innovative analytical technology that performs quantitative immunoassays and cell based assays. With the help of on-the-spot testing, companies in the syphilis immunoassay diagnostics market can tap into new business models, such as providing analytical testing services to the veterinary, food, military sectors.
Companies in the syphilis immunoassay diagnostics market are focused on expanding their product portfolios. They are increasing efforts to manufacture and sell instruments by acquiring licensing for the same. By these efforts, they are supporting the global OEM supply business model associated with various assays and their applications.
Healthcare industries are developing multiplexed immunoassay systems by experimenting on planar waveguide technology and fluorescence imaging. These efforts are being made to support outcomes in the ELISA (enzyme-linked immunosorbent assay) test, since ELISA currently accounts for the highest revenue in the syphilis immunoassay diagnostics market.
Get a glimpse of the in-depth analysis through our Report Brochure
Recent advancements in molecular biology have led to the popularity of molecular diagnosis, such as the polymerase chain reaction (PCR), in the syphilis immunoassay diagnostics ecosystem. PCR technology is playing a crucial role in diagnosing syphilis. Healthcare industries in the syphilis immunoassay diagnostics market are developing various PCR methodologies that can be easily adapted in the clinical and laboratory environment. PCR is being increasingly associated with widespread application and deep exploration in the healthcare space.
Fast developments in PCR have led to advancements in real-time PCR, nested PCR, and multiplex PCR. The high sensitivity and specificity of PCR is well-suited for the diagnosis of early-stage syphilis. On the other hand, routine PCR is well-received in secondary syphilis. Healthcare companies in the syphilis immunoassay diagnostics market are increasing R&D to detect atypical cases of vertebral, ocular, and tonsillar syphilis with the help of molecular biology. Real-time PCR is gaining increased popularity for its ability to calculate the sum of pathogens that reveal the severity of the infection.
Companies Improve Access to Testing Technologies in LMICs to Prevent Maternal Syphilis
The issue of maternal and child mortality due to syphilis and HIV/AIDS is distinctly prevalent in low- and middle-income countries (LMICs). This is why, healthcare industries in the syphilis immunoassay diagnostics market are increasing efforts to improve child and maternal health through antenatal care.
At the same time, companies in the syphilis immunoassay diagnostics space are innovating in point of care diagnostic services. Although healthcare industries are making progress in the prevention of mother-to-child transmission, several new cases of pediatric infections are still being reported. Thus, companies in the syphilis immunoassay diagnostics market should improve access to new testing technologies that will reduce the incidence of syphilis infection in LMICs. Along with testing for syphilis, companies should offer convenient testing options such as the dual HIV/syphilis rapid diagnostics test to help patients assess the prevalence of any other bacterial infections.
Companies in the syphilis immunoassay diagnostics ecosystem are also increasing the availability of antenatal rapid syphilis testing in LMICs. Undiagnosed and untreated maternal syphilis has catalyzed the demand for antenatal rapid syphilis testing.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
Kits and reagents are projected for high growth in the syphilis immunoassay diagnostics market. Apart from manual testing, healthcare companies are turning toward automating high-quality syphilis test kits with the use of state-of-the-art machines. FDA-cleared automated analyzers are also triggering market growth.
Healthcare providers are increasingly replacing labor-intensive reading with full automatic results that meet the 'results-per-hour' demand. However, the transmission of syphilis during blood donation poses a huge risk for healthcare providers. Hence, companies should educate healthcare providers about thorough health consultation and screening of high-risk groups before blood donation. Companies should invest in developing robust clinical chemistry analyzers that provide automation-ready immunoassays.
Syphilis Immunoassay Diagnostics Market and Report Description
Syphilis Immunoassay Diagnostics Market: Drivers
Global Syphilis Immunoassay Diagnostics Market: Key Segments
Global Syphilis Immunoassay Diagnostics Market: Trends
Global Syphilis Immunoassay Diagnostics Market: Major Players
Global Syphilis Immunoassay Diagnostics Market - Segmentation
TMR’s study on the global syphilis immunoassay diagnostics market includes information divided into four sections - by product, by technology, by end user, and by region. Changing industry trends and other crucial market dynamics associated with these sections of the global syphilis immunoassay diagnostics market have been discussed in detail.
|
Product |
|
|
Technology |
|
|
End User |
|
|
Region |
|
Syphilis immunoassay diagnostics market is projected to reach ~US$ 380 Mn by 2027
Syphilis immunoassay diagnostics market is projected to expand at a CAGR of ~2% during 2019 - 2027
Syphilis immunoassay diagnostics market is driven by increase in prevalence of HIV infections across the globe
The chemiluminescence immunoassay (CLIA) segment segment dominated the global syphilis immunoassay diagnostics market
Key players in the global syphilis immunoassay market include Bio Rad Laboratories, Inc., Becton, F. Hoffmann la Roche Ltd., DiaSorin S.p.A., Ortho Clinical Diagnostics (part of the Carlyle Group)
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Syphilis Immunoassay Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Class Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Technological Advancement
5.2. Key Merger & Acquisition
5.3. Top Three Players- Analysis
5.4. Number of Syphilis Diagnostic Test, by Technology (2018)
5.5. Pricing Analysis by Technology
5.6. Disease Prevalence & Incidence Rate
6. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Product, 2017-2027
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2027
6.3.1. Analyzers
6.3.2. Kits & Reagents
6.4. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by Product
7. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Technology, 2017-2027
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017–2027
7.3.1. ELISA
7.3.2. CLIA
7.3.3. Others
7.4. Market Attractiveness, by Technology
8. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017–2027
8.3.1. Hospitals
8.3.2. Diagnostics Labs
8.3.3. Blood Banks
8.3.4. Others
8.4. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by End-user
9. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Region, 2017-2027
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by Region
10. North America Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
10.1. Introduction
10.1.1. Key Findings
10.2. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017–2027
10.2.1. Analyzers
10.2.2. Kits & Reagents
10.3. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
10.3.1. ELISA
10.3.2. CLIA
10.3.3. Others
10.4. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
10.4.1. Hospitals
10.4.2. Diagnostics Labs
10.4.3. Blood Banks
10.4.4. Others
10.5. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Country, 2017-2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Technology
10.6.3. By End-user
10.6.4. By Country
11. Europe Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
11.1. Introduction
11.1.1. Key Finding
11.2. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
11.2.1. Analyzers
11.2.2. Kits & Reagents
11.3. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
11.3.1. ELISA
11.3.2. CLIA
11.3.3. Others
11.4. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
11.4.1. Hospitals
11.4.2. Diagnostic Labs
11.4.3. Blood Banks
11.4.4. Others
11.5. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Russia
11.5.7. Turkey
11.5.8. Eastern Europe
11.5.9. Rest of Europe
11.6. Europe Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Technology
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
12.1. Introduction
12.1.1. Key Finding
12.2. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
12.2.1. Analyzers
12.2.2. Kits & Reagents
12.3. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
12.3.1. ELISA
12.3.2. CLIA
12.3.3. Others
12.4. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
12.4.1. Hospitals
12.4.2. Diagnostic Labs
12.4.3. Blood Banks
12.4.4. Others
12.5. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. South Korea
12.5.6. Vietnam
12.5.7. Rest of Asia Pacific
12.6. Asia Pacific Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Technology
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
13.1. Introduction
13.1.1. Key Finding
13.2. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
13.2.1. Analyzers
13.2.2. Kits & Reagents
13.3. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
13.3.1. ELISA
13.3.2. CLIA
13.3.3. Others
13.4. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
13.4.1. Hospitals
13.4.2. Diagnostic Labs
13.4.3. Blood Banks
13.4.4. Others
13.5. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast by Country/Sub-region, 2017-2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Technology
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
14.1. Introduction
14.1.1. Key Finding
14.2. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
14.2.1. Analyzers
14.2.2. Kits & Reagents
14.3. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
14.3.1. ELISA
14.3.2. CLIA
14.3.3. Others
14.4. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
14.4.1. Hospitals
14.4.2. Diagnostic Labs
14.4.3. Blood Banks
14.4.4. Others
14.5. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Maghreb
14.5.4. Rest of Middle East & Africa
14.6. Middle East & Africa Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Technology
14.6.3. By End-users
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis by Company (2018)
15.3. Company Profiles
15.3.1. F. Hoffmann-La Roche AG
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Bio-Rad Laboratories, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. BD
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Siemens Healthineers AG
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. DiaSorin S.p.A.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Abbott
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Ortho Clinical Diagnostics (a part of Carlyle Group)
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Shenzhen New Industries Biomedical Engineering Co., Ltd.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. bioMérieux SA
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. Fujirebio (Miraca Group) (Miraca Group)
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Company Financials
15.3.10.3. Growth Strategies
15.3.10.4. SWOT Analysis
15.3.11. Fujirebio (Miraca Group)
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Company Financials
15.3.11.3. Growth Strategies
15.3.11.4. SWOT Analysis
15.3.12. Danaher (Beckman Coulter, Inc.)
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Company Financials
15.3.12.3. Growth Strategies
15.3.12.4. SWOT Analysis
List of Tables
Table 01: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
Table 02: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
Table 03: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 04: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017 - 2027
Table 05: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017 - 2027
Table 06: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
Table 07: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
Table 08: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 09: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
Table 10: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
Table 11: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
Table 12: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 13: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
Table 14: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
Table 15: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
Table 16: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 17: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
Table 18: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
Table 19: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
Table 20: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 21: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
Table 22: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
Table 23: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
Table 24: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast,
List of Figures
Figure 01: Global Syphilis Diagnostics Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Market Opportunity Map, by Product, 2018
Figure 03: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027
Figure 04: Global Syphilis Diagnostics Market Value Share, by Product, 2018
Figure 05: Global Syphilis Diagnostics Market Value Share, by Technology, 2018
Figure 06: Global Syphilis Diagnostics Market Value Share, by End-user, 2018
Figure 07: Global Syphilis Diagnostics Market Value Share, by Region, 2018
Figure 08: Global Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
Figure 09: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Analyzers, 2017 - 2027
Figure 10: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Kits & Reagents, 2017 - 2027
Figure 11: Global Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027
Figure 12: Global Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027
Figure 13: Global Syphilis Diagnostics Market Value (US$ Mn), by ELISA Test, 2017 - 2027
Figure 14: Global Syphilis Diagnostics Market Value (US$ Mn), by CLIA Test, 2017 - 2027
Figure 15: Global Syphilis Diagnostics Market Value (US$ Mn), by Others, 2017 - 2027
Figure 16: Global Syphilis Diagnostics Market Attractiveness, by Technology, 2019 - 2027
Figure 17: Global Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
Figure 18: Global Syphilis Diagnostics Market Value (US$ Mn), by Hospitals, 2017 - 2027
Figure 19: Global Syphilis Diagnostics Market Value (US$ Mn), by Diagnostic Labs, 2017 - 2027
Figure 20: Global Syphilis Diagnostics Market Value (US$ Mn), by Blood Banks, 2017 - 2027
Figure 21: Global Syphilis Diagnostics Market Value (US$ Mn), by Others, 2017 - 2027
Figure 22: Global Syphilis Diagnostics Market Attractiveness, by End-user, 2019 - 2027
Figure 23: Global Syphilis Diagnostics Market Value Share Analysis, by Region, 2018 and 2027
Figure 24: Global Syphilis Diagnostics Market Attractiveness Analysis, by Region, 2019 - 2027
Figure 25: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027
Figure 26: North America Syphilis Diagnostics Market Attractiveness Analysis, by Country, 2019 - 2027
Figure 27: North America Syphilis Diagnostics Market Value Share Analysis, by Country, 2018 and 2027
Figure 28: North America Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
Figure 29: North America Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027
Figure 30: North America Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
Figure 31: North America Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027
Figure 32: North America Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027
Figure 33: North America Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027
Figure 34: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027
Figure 35: Europe Syphilis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019 - 2027
Figure 36: Europe Syphilis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 37: Europe Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
Figure 38: Europe Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027
Figure 39: Europe Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
Figure 40: Europe Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027
Figure 41: Europe Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027
Figure 42: Europe Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027
Figure 43: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027
Figure 44: Asia Pacific Syphilis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019 - 2027
Figure 45: Asia Pacific Syphilis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 46: Asia Pacific Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
Figure 47: Asia Pacific Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027
Figure 48: Asia Pacific Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
Figure 49: Asia Pacific Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027
Figure 50: Asia Pacific Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027
Figure 51: Asia Pacific Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027
Figure 52: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027
Figure 53: Latin America Syphilis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019 - 2027
Figure 54: Latin America Syphilis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 55: Latin America Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
Figure 56: Latin America Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027
Figure 57: Latin America Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
Figure 58: Latin America Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027
Figure 59: Latin America Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027
Figure 60: Latin America Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027
Figure 61: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027
Figure 62: Middle East & Africa Syphilis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019 - 2027
Figure 63: Middle East & Africa Syphilis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 64: Middle East & Africa Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
Figure 65: Middle East & Africa Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027
Figure 66: Middle East & Africa Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
Figure 67: Middle East & Africa Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027
Figure 68: Middle East & Africa Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027
Figure 69: Middle East & Africa Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027
Figure 70: Danaher Diagnostics Business Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
Figure 71: R&D Intensity (US$ Mn), Diagnostics Business Segment, 2015–2017
Figure 72: Breakdown of Net Sales (%), Danaher Diagnostics Business Segment, by Region, 2018
Figure 73: Breakdown of Net Sales (%), Danaher Diagnostics Business Segment, by Product, 2018
Figure 74: Becton, Dickinson. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
Figure 75: Becton, Dickinson. Breakdown of Net Sales (%), by Region/Country, 2018
Figure 76: Becton, Dickinson. Revenue Breakdown of Net Sales (%), by Business Segment, 2018
Figure 77: Becton, Dickinson. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 78: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
Figure 79: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
Figure 80: Breakdown of Net Sales (% Share), by Business Segment, 2018
Figure 81: Breakdown of Net Sales (% Share), by Region, 2018
Figure 82: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
Figure 83: R&D Expenses (US$ Mn), 2015 - 2018
Figure 84: Breakdown of Net Sales (% Share), by Business Segment (2018)
Figure 85: Breakdown of Net Sales (% Share), by Region (2018)
Figure 86: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
Figure 87: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
Figure 88: Breakdown of Net Sales (%), by Business Segment, 2018
Figure 89: Breakdown of Net Sales (%), by Region/Country, 2018
Figure 90: DiaSorin S.p.A. Revenue (US$ Mn), 2015 - 2018
Figure 91: DiaSorin S.p.A. R&D Expenses (US$ Mn), 2015 - 2018
Figure 92: DiaSorin S.p.A. Sales and Marketing Expenses (US$ Mn, 2015 - 2018
Figure 93: DiaSorin S.p.A. Breakdown of Net Sales (%), by Region, 2018
Figure 94: DiaSorin S.p.A. Breakdown of Net Sales (%), by Business Segment, 2018
Figure 95: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
Figure 96: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
Figure 97: Breakdown of Net Sales (% Share), by Business Segment, 2018
Figure 98: Breakdown of Net Sales (% Share), by Region, 2018
Figure 99: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
Figure 100: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
Figure 101: Breakdown of Net Sales (% Share), by Application, 2018
Figure 102: Breakdown of Net Sales (% Share), by Region, 2018
Figure 103: Miraca Group (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
Figure 104: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Syphilis Immunoassay Diagnostics Market
*86 figures and 60 tables includes